Viral evolution in response to the broad-based retroviral protease inhibitor TL-3.
about
Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3Crystal structure of an FIV/HIV chimeric protease complexed with the broad-based inhibitor, TL-3Fragment-Based Screen against HIV ProteaseStructural basis for drug and substrate specificity exhibited by FIV encoding a chimeric FIV/HIV proteaseSmall Molecule Regulation of Protein Conformation by Binding in the Flap of HIV ProteaseA look inside HIV resistance through retroviral protease interaction mapsIdentification of broad-based HIV-1 protease inhibitors from combinatorial librariesGeneration of infectious feline immunodeficiency virus (FIV) encoding FIV/human immunodeficiency virus chimeric protease.Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system.Evaluation of different antiretroviral drug protocols on naturally infected feline immunodeficiency virus (FIV) cats in the late phase of the asymptomatic stage of infection.Selection of drug-resistant feline immunodeficiency virus (FIV) encoding FIV/HIV chimeric protease in the presence of HIV-specific protease inhibitorsResolution and prevention of feline immunodeficiency virus-induced neurological deficits by treatment with the protease inhibitor TL-3.A copper(I)-catalyzed 1,2,3-triazole azide-alkyne click compound is a potent inhibitor of a multidrug-resistant HIV-1 protease variant.A cleavage enzyme-cytometric bead array provides biochemical profiling of resistance mutations in HIV-1 Gag and protease.
P2860
Q24801797-AAEAACE2-C5B7-42E0-9CD2-8DB73DCA5AE0Q27641090-804280D2-4959-4D89-9112-8220BD8F8618Q27663595-FF12B17A-D005-47E0-83E5-DD9D38025EC6Q27668150-E188562D-4DCF-43EE-861A-173B6D9F9347Q27677124-028EBD6F-5F32-4110-8F13-B64E22EF06A5Q28469157-337E132B-DD91-4E1F-8643-97834E977993Q33589171-69679FF4-FC07-44D6-BA71-064244D1286DQ33990752-1CC4F082-0D3F-49C9-BF45-CD3F0F98C730Q35024024-F4F5DC2E-9422-4154-A7AD-0C98368151F1Q36096402-AC9AC08C-79FB-4B86-BB95-1B1BD94350B4Q37036823-7F0A3EBA-AD60-4DDB-B6D4-26A69C9AF3CBQ37423412-315DA8BD-727D-4417-96CE-9B296289B3B2Q39934806-F982AFBC-550E-4728-AD84-E553DCBE99BFQ42872702-4A832DF9-0648-4FC8-B547-CF634D62E929
P2860
Viral evolution in response to the broad-based retroviral protease inhibitor TL-3.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Viral evolution in response to the broad-based retroviral protease inhibitor TL-3.
@ast
Viral evolution in response to the broad-based retroviral protease inhibitor TL-3.
@en
type
label
Viral evolution in response to the broad-based retroviral protease inhibitor TL-3.
@ast
Viral evolution in response to the broad-based retroviral protease inhibitor TL-3.
@en
prefLabel
Viral evolution in response to the broad-based retroviral protease inhibitor TL-3.
@ast
Viral evolution in response to the broad-based retroviral protease inhibitor TL-3.
@en
P2093
P2860
P1433
P1476
Viral evolution in response to the broad-based retroviral protease inhibitor TL-3.
@en
P2093
B E Torbett
D D Richman
P2860
P304
P356
10.1128/JVI.75.19.9502-9508.2001
P577
2001-10-01T00:00:00Z